cmAngio® vs HealthCCSng

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

cmAngio®

by CureMetrix

HealthCCSng

by Nano-X AI

AI Verdict

Tool A detects Breast Arterial Calcifications (BAC) on mammograms to provide insights into cardiovascular health, making it relevant for breast imaging workflows. In contrast, Tool B analyzes routine CT scans to quantify Coronary Artery Calcification (CAC), directly identifying patients at risk of coronary artery disease. While both contribute to cardiovascular risk assessment through AI-detected calcifications, they utilize different imaging modalities and target distinct anatomical calcifications, making them complementary rather than direct competitors.

Choose cmAngio® if…

Choose cmAngio® if your primary goal is to leverage existing mammography screenings to gain insights into women's cardiovascular health. This tool is ideal for integrating early cardiovascular risk assessment into routine breast imaging workflows, identifying Breast Arterial Calcifications (BAC) without requiring additional radiation or procedures for the patient. It's particularly well-suited for practices looking for a quick-to-install, AI-powered solution compatible with any DICOM viewer to enhance women's health initiatives.

View cmAngio® →

Choose HealthCCSng if…

Choose HealthCCSng if you aim to automatically detect and quantify Coronary Artery Calcification (CAC) from routine, non-contrast chest CT scans to identify patients at risk of coronary artery disease. This solution is best for practices seeking to opportunistically assess cardiovascular risk by utilizing existing imaging data, providing a numerical calcium score and seamless integration with PACS and EMR systems for an automated workflow. It's particularly valuable for leveraging incidental findings on CT scans to proactively manage cardiac health.

View HealthCCSng →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	cmAngio®	HealthCCSng
Pricing	Paid, out-of-pocket	Not publicly available
Deployment	Cloud-based, integrates with any DICOM-compliant viewer	Cloud-based, integrates with PACS and EMR systems
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	cmAngio®	HealthCCSng
Name	cmAngiou00ae	HealthCCSng
Company	CureMetrix	Nano-X AI
Primary Detection Target	Breast Arterial Calcifications (BAC)	Coronary Artery Calcification (CAC)
Input Imaging Modality	Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams	Non-contrast, non-ECG gated chest CT scans
Key Output/Reporting	Visualization of BAC location on a scorecard; BAC identification and reporting; adjustable operating point	Automatic detection and quantification of CAC; categorization into 'zero', 'low', 'moderate', 'severe' CAC; numerical calcium score; visualization of calcified plaques
Integration	Compatible with any DICOM-compliant viewer	Seamless integration with PACS and EMR systems

Videos

Demos, reviews, and walkthroughs featuring cmAngio® and HealthCCSng.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific type of calcification does each AI tool detect and from what imaging modality?

cmAngiou00ae by CureMetrix is designed to detect Breast Arterial Calcifications (BAC) on mammograms, including both Full-Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) exams. HealthCCSng by Nano-X AI analyzes routine non-contrast, non-ECG gated chest CT scans to automatically detect and quantify coronary artery calcification (CAC).

How do the clinical insights provided by each tool differ for patient care?

cmAngiou00ae provides insights into cardiovascular health and aids early risk assessment by identifying and visualizing BAC on a scorecard. HealthCCSng identifies patients at risk of coronary artery disease by automatically detecting and quantifying CAC, categorizing studies into 'zero', 'low', 'moderate', and 'severe' categories, and generating a numerical calcium score.

What are the integration requirements for each AI solution within a clinical workflow?

cmAngiou00ae is compatible with any DICOM-compliant viewer and boasts quick and easy installation. HealthCCSng offers seamless integration with existing Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) systems.

Which medical specialties are these AI tools primarily designed to serve?

cmAngiou00ae is relevant for Cardiology, Obstetrics & Gynecology, and Radiology specialties. HealthCCSng primarily serves Cardiology and Radiology specialties.

What kind of output or reporting can physicians expect from each tool?

cmAngiou00ae provides visualization of BAC location on a scorecard and enables BAC identification and reporting without additional radiation or procedures. HealthCCSng automatically detects and quantifies CAC, categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, generates a numerical calcium score, and provides visualization of calcified plaques within coronary arteries.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring cmAngio® or HealthCCSng

Backers

Who funded each tool's parent company.

cmAngio®

Keshif Ventures